News
Assessment of interchangeability under the BPCI Act
2013-05-22 The Biologics Price Competition and Innovation (BPCI) Act gives FDA the authority to designate a biosimilar as interchangeable with its reference product. This means that… Read More »
Biologicals in EU to be identified by brand names
2013-05-20 The European Commission has issued a directive which requires biological products to be identified by brand name and not by international nonproprietary name (INN). The… Read More »
MEPs adopt directive to give quicker access to generics
2013-05-17 Members of the European Parliament (MEPs) have adopted the text of the Transparency Directive 2012/0035(COD) by a large majority in a plenary session of the… Read More »
Biosimilars to replace 70% of chemical drugs
2013-05-15 Biosimilars will replace some 70% of global chemical drugs over the next couple of decades, according to industry experts. This replacement will occur due to… Read More »
Inequality in Europe over access to biologicals for arthritis
2013-05-13 Data from a study presented at the European League Against Rheumatism’s Annual European Congress of Rheumatology, EULAR Congress 2012, demonstrates the vast inequalities in access… Read More »
Generics policies in Europe have room for improvement
2013-05-10 In Europe, generics policies have not yet been implemented to their full extent, according to authors Vogler and Zimmerman, reporting on the 2011 Pharmaceutical Pricing… Read More »
Medicines spending in Brazil
2013-05-08 The Brazilian pharmaceutical market is the third largest in the Americas region, behind the US and Canada; it ranks first in the Latin American region.… Read More »
G-CSF biosimilars – World Marrow Donor Association position
2013-05-06 The World Marrow Donor Association (WMDA) has expressed its position on the use of granulocyte colony-stimulating factor (G-CSF) biosimilars in healthy donors in an article… Read More »
Prescribing in Scotland increases but drug costs drop
2013-05-03 Spending on medicine in Scotland was 11% less in 2011–2012 compared to spending in 2004–2005. This is despite the volume of prescriptions increasing by 33%… Read More »
Generic Doxil approval may help alleviate drug shortages
2013-05-01 FDA announced on 4 February 2013 that the agency had approved the first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection). Liposomal… Read More »
